Quarterly report pursuant to Section 13 or 15(d)

RESTATEMENT OF PRIOR FINANCIAL STATEMENTS (Details)

v3.22.1
RESTATEMENT OF PRIOR FINANCIAL STATEMENTS (Details) - USD ($)
Sep. 30, 2021
Jun. 30, 2021
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Dec. 31, 2019
Deferred Revenue - Participation Agreements $ 0          
Deferred R&D Obligations - Participation Agreements 1,681,004          
Total Current Liabilities 3,197,561   $ 11,393,915      
Total Liabilities 3,200,961   11,530,793      
Accumulated deficit (104,712,643)   (99,063,675)      
Total Stockholders' Equity (Deficit) 7,770,629 $ 7,332,972 $ (11,310,614) $ (11,090,848) $ (9,992,974) $ (8,338,483)
As Reported [Member]            
Deferred Revenue - Participation Agreements 2,031,103          
Deferred R&D Obligations - Participation Agreements 0          
Total Current Liabilities 3,547,660          
Total Liabilities 3,551,060          
Accumulated deficit (105,062,742)          
Total Stockholders' Equity (Deficit) 7,420,530          
Adjustment [Member]            
Deferred Revenue - Participation Agreements 2,031,103          
Deferred R&D Obligations - Participation Agreements 1,681,004          
Total Current Liabilities 350,099          
Total Liabilities 350,099          
Accumulated deficit 350,099          
Total Stockholders' Equity (Deficit) $ 350,099